Trial Profile
Efficacies of Entecavir Add on Chronic Hepatitis B Patients With HBV DNA Load ≥1000 Copies/ml After 6 Months Treatment of Peginterferon Alpha 2a
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2018
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis B
- Focus Therapeutic Use
- 18 Aug 2016 Status changed from active, no longer recruiting to recruiting.
- 28 Feb 2015 New trial record